For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Research and development | 182,373 | |||
| General and administrative | 52,015 | |||
| Total operating expenses | 234,388 | |||
| Loss from operations | -234,388 | |||
| Interest income | 4,517 | |||
| Interest expense | 0 | |||
| Other income (expense), net | -96 | |||
| Net loss | -229,967 | |||
| Change in unrealized gains (losses) related to available-for-sale debt securities, net of tax | 0 | |||
| Total other comprehensive income (loss) | 0 | |||
| Comprehensive loss | -229,967 | |||
| Basic EPS | -4.32 | |||
| Diluted EPS | -4.32 | |||
| Basic Average Shares | 53,208,311 | |||
| Diluted Average Shares | 53,208,311 | |||
Kodiak Sciences Inc. (KOD)
Kodiak Sciences Inc. (KOD)